An Arizona Senate committee convened a special oversight hearing last week to examine why patients in the state’s American Indian Health Program are being denied addiction and behavioral health treatment despite facility capacity.
The hearing, led by the Arizona Senate Health and Human Services Committee under Chair Senator Carine Werner (R-LD4), follows months of testimony from families, treatment providers, and whistleblowers who raised alarms about deep-rooted barriers within the Arizona Health Care Cost Containment System (AHCCCS), the state’s Medicaid program.
Among the most pressing issues: reimbursement failures that prevent providers in the American Indian Health Program (AIHP) from scheduling new patient care, inadequate provider networks, unresolved audit findings, and gaps in oversight of public funds.
“When patients are being turned away from care, or providers cannot get paid for services already delivered, that is a serious breakdown in the system,” Werner said at the hearing. “These issues did not happen overnight. They developed over many years, and it is the Legislature’s responsibility to conduct oversight, ask tough questions, and ensure the program is working the way taxpayers and patients expect it to.”
AHCCCS came under scrutiny in 2023 when news broke of a $2 billion sober living home scheme targeting Native Americans. While legislation has been passed to increase the oversight of the system that allowed the fraud to thrive undetected for years, it still continues
LaWerner introduced a package of seven reform bills currently advancing through the Arizona House. The legislation targets accountability, patient protections, fraud prevention, and access to behavioral health services — with particular attention to Native American communities served through the AIHP. The package includes:
- SB 1114: Appropriates $1 million from the state general fund in FY 2026–2027 to the State Treasurer for distribution to the Maricopa County Attorney’s Office to support investigations and prosecutions of behavioral health patient brokering schemes, where vulnerable individuals are illegally trafficked between facilities for profit rather than receiving appropriate care.
- SB 1116: Requires that any denial of behavioral health treatment under the AIHP—based on medical necessity—be reviewed and approved by a qualified clinician with at least two years of relevant experience in similar services before a claim can be rejected.
- SB 1122: Limits excessive 100% prepayment reviews for behavioral health services under the AIHP, prohibiting such requirements beginning January 1, 2027, unless a provider is noncompliant with or disengaged from a corrective action plan, to reduce delays in patient care.
- SB 1173: Strengthens safety standards for behavioral health facilities by mandating, beginning January 1, 2027, that owners, operators, applicants, and licensees of specified facilities be U.S. citizens or lawful permanent residents and hold valid fingerprint clearance cards.
- SB 1233: Provides facilities with a 72-hour cure period to correct minor administrative deficiencies—those not impacting patient physical or psychological well-being—before state agencies can take disciplinary or enforcement action.
- SB 1611: Reforms AIHP administration by requiring AHCCCS, beginning October 1, 2027, to contract with a qualified administrative services organization for functions like program integrity, care management, provider support, quality improvement, data analytics, and claims payment. The bill preserves the fee-for-service option for eligible American Indian members, mandates tribal consultation, includes tribal observers in procurement, establishes an Office of Tribal Relations, and requires quarterly consultations to ensure quality care.
- SB 1814: Establishes the bipartisan Substance Use Disorder Treatment Standards and Oversight Study Committee, comprising legislative members, state officials, clinicians, physicians, and advocates. The committee will assess treatment availability, identify gaps in evidence-based care, review regulatory loopholes enabling fraud or substandard programs, recommend minimum clinical standards, safety requirements, and funding models, and submit a report with proposed changes by December 31, 2027.